A series of cytology assays testified that overexpressing FBP1 could inhibit the proliferation, migration, and invasion of liver cancer cells and promote cell apoptosis, which indicated that FBP1 was a cancer inhibitor in liver cancer. Here, FBP1 is linked to liver cancer.